These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The value of vaccines: our nation's front line against infectious diseases. Gellin B; Landry S Clin Pharmacol Ther; 2010 Nov; 88(5):580-1. PubMed ID: 20959840 [No Abstract] [Full Text] [Related]
4. Preventing the use of biological weapons: improving response should prevention fail. Inglesby TV; O'Toole T; Henderson DA Clin Infect Dis; 2000 Jun; 30(6):926-9. PubMed ID: 10880302 [TBL] [Abstract][Full Text] [Related]
5. [Proactive epidemic control in Germany--comprehensive smallpox vaccination of German population. Legal assessment]. Jungk A Krankenpfl J; 2003; 41(1-3):45-6. PubMed ID: 12718272 [No Abstract] [Full Text] [Related]
6. Vaccines for the prevention of diseases caused by potential bioweapons. Hassani M; Patel MC; Pirofski LA Clin Immunol; 2004 Apr; 111(1):1-15. PubMed ID: 15093546 [TBL] [Abstract][Full Text] [Related]
7. [Biological warfare: disease prevention and post exposure medical treatment]. Robenshtok E; Katz L; Brenner B; Sagi R Harefuah; 2002 May; 141 Spec No():57-62, 121. PubMed ID: 12170556 [TBL] [Abstract][Full Text] [Related]
11. U.S. State department accuses several nations of having offensive biological weapons programs. Mair M; Franco C Biosecur Bioterror; 2005; 3(4):279-80. PubMed ID: 16392159 [No Abstract] [Full Text] [Related]
12. Introduction to this supplement. Barrett AD; Lu S; Poland GA Vaccine; 2009 Nov; 27 Suppl 4():D1. PubMed ID: 19837278 [No Abstract] [Full Text] [Related]
13. [Hygienic and antiepidemic measures to combat communicable diseases within the scope of medical protection of the population]. Hackenberg HW; Steiner ER Z Arztl Fortbild (Jena); 1969 Apr; 63(8):409-14. PubMed ID: 5817717 [No Abstract] [Full Text] [Related]
14. Immunization to protect the US Armed Forces: heritage, current practice, and prospects. Grabenstein JD; Pittman PR; Greenwood JT; Engler RJ Epidemiol Rev; 2006; 28():3-26. PubMed ID: 16763072 [TBL] [Abstract][Full Text] [Related]
15. Old legacies and new paradigms: confusing "research" and "treatment" and its consequences in responding to emergent health threats. Javitt GH J Health Care Law Policy; 2005; 8(1):38-70. PubMed ID: 16538801 [No Abstract] [Full Text] [Related]
16. Preventive vaccines against bioterrorism: evaluation of efficacy and safety. Horne AD; Clifford J; Goldenthal KL; Kleppinger C; Lachenbruch PA Vaccine; 2004 Nov; 23(1):84-90. PubMed ID: 15519711 [TBL] [Abstract][Full Text] [Related]
17. [Consequences and challenges due to bioterrorist attacks]. Kurth R Gesundheitswesen; 2002 Dec; 64(12):689-91. PubMed ID: 12516022 [TBL] [Abstract][Full Text] [Related]
19. National Advisory Committee on SARS and Public Health (Naylor) report. Healthc Q; 2004; 7(3):30-5. PubMed ID: 15230164 [No Abstract] [Full Text] [Related]